MMI receives €17M EIB–Angelini Ventures co-investment
Medical Microinstruments received a new €17M co-investment from the European Investment Bank and Angelini Ventures to support its microsurgery robotics business.
Evidence notes
- The financing is the third completed investment under the investors’ €150M European life-sciences programme.
- MMI manufactures the Symani system in Pisa for microsurgery and super-microsurgery.
- EIB and Angelini Ventures each committed €75M to the six-year co-investment programme, which targets 7–10 European companies.
Company overview
Surgical-robotics company developing the Symani system for microsurgery and supermicrosurgery.